Cascades Inc
OTC:CADNF

Watchlist Manager
Cascades Inc Logo
Cascades Inc
OTC:CADNF
Watchlist
Price: 9.54 USD Market Closed
Market Cap: $960.7m

Cascades Inc
Investor Relations

Cascades, Inc. produces, converts and markets packaging and tissue products composed mainly of recycled fibres. The company is headquartered in Kingsey Falls, Quebec and currently employs 10,000 full-time employees. The Company’s segments include Containerboard, Specialty Products (which constitutes the Company's Packaging Products) and Tissue Papers. The Containerboard segment is a manufacturer of containerboard and converter of corrugated products in North America. The Specialty Products Group manufactures industrial and food packaging products. The Tissue Papers segment manufactures tissue paper reels and converts them into finished products for the professional and residential markets. The firm also provides recycling solutions. The company operates approximately 80 production units throughout North America.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Strong Quarter: Cascades delivered better-than-expected Q3 results, driven by higher volumes, improved selling prices, and lower production costs.

Profitability Momentum: Consolidated EBITDA rose 16% sequentially and 14% year-over-year, reflecting benefits from ongoing profitability initiatives.

Packaging Outperformance: Packaging EBITDA increased 14% from Q2 with margins rising to 17.1%; Bear Island ramp-up and Niagara Falls closure both progressed ahead of plan.

Tissue Improvements: Tissue EBITDA rose 21% sequentially, aided by stronger volumes and lower operating costs.

Debt Reduction: Net debt fell by $81 million in Q3, and the company is prioritizing free cash flow for further debt repayment.

Asset Monetization Target Raised: Asset sale target was increased to $120 million by mid-2026, up from $80 million previously.

Q4 Outlook Cautious: Packaging results are expected to be flat to down 10% in Q4 due to anticipated seasonal volume declines and macro uncertainty; Tissue expected to strengthen.

Profitability Initiatives: Company on track for $100 million run rate improvement by end of 2026, with $10 million contributed in Q3.

Key Financials
Consolidated EBITDA
$159 million
Packaging EBITDA
$136 million
Packaging EBITDA Margin
17.1%
Bear Island Mill Production
102,000 tons
Bear Island Operating Rate
90% of ramp-up curve; 88% of capacity
Tissue EBITDA
$46 million
Leverage Ratio
3.6x
Available Liquidity
$630 million
Adjusted Cash Flow from Operations
$137 million
Net Earnings Per Share
$0.29
Adjusted Earnings Per Share
$0.38
Capital Expenditures (Q3)
$30 million
Capital Expenditures (2025 full-year guidance)
$140 million
Capital Expenditures (2026 guidance)
$175 million
Asset Monetization Target
$120 million by June 2026
Proceeds from Asset Sales (2024 YTD)
$57 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Alain Lemaire Ph.D.
Co-Founder & Director
No Bio Available
Mr. Allan Hogg CA
VP & CFO
No Bio Available
Mr. Mario Plourde
Executive Officer
No Bio Available
Mr. Luc Langevin
Senior Vice President of Cascades Services
No Bio Available
Mr. Jean-David Tardif
Executive Vice-President of Packaging
No Bio Available
Mr. Hugues Simon
President & CEO
No Bio Available
Mr. Dominic Doré
Chief Supply Chain & Information Officer
No Bio Available
Ms. Jennifer Aitken
Director of Investor Relations
No Bio Available
Mr. Robert F. Hall
Chief of Strategy & Legal Affairs
No Bio Available
Mr. Hugo D'Amours
Vice-President, Communications, Public Affairs & Sustainable Development
No Bio Available

Contacts

Address
QUEBEC
Kingsey Falls
404 Marie-Victorin Blvd
Contacts
+18193635100.0
www.cascades.com